JFL Life Sciences (NSE:JFLLIFE) Ending Cash Position: ₹8.6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JFLLIFE JFL Life Sciences Ltd NSE:JFLLIFE
76 GF Score
Price ₹9.80
GF Value ₹36.85
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is JFL Life Sciences Ending Cash Position?

JFL Life Sciences NSE:JFLLIFE -3.79% 76 Ending Cash Position is ₹8.6 Mil as of Mar. 2026. GuruFocus rates NSE:JFLLIFE with a GF Score™ of 76/100 and a GF Value™ of ₹36.85 (Significantly Undervalued). The stock has 2 warning signs investors should review.

JFL Life Sciences's Ending Cash Position for the quarter that ended in Mar. 2026 was ₹8.6 Mil.

JFL Life Sciences's quarterly Ending Cash Position declined from Mar. 2024 (₹0.3 Mil) to Mar. 2025 (₹0.3 Mil) but then increased from Mar. 2025 (₹0.3 Mil) to Mar. 2026 (₹8.6 Mil).

JFL Life Sciences's annual Ending Cash Position declined from Mar. 2024 (₹0.3 Mil) to Mar. 2025 (₹0.3 Mil) but then increased from Mar. 2025 (₹0.3 Mil) to Mar. 2026 (₹8.6 Mil).

JFL Life Sciences Ending Cash Position Related Terms

JFL Life Sciences Ending Cash Position Historical Data

* Premium members only.

The historical data trend for JFL Life Sciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences Ending Cash Position Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Ending Cash Position
Get a 7-Day Free Trial 1.90 0.59 0.34 0.34 8.63

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Ending Cash Position Get a 7-Day Free Trial 1.90 0.59 0.34 0.34 8.63
NSE:JFLLIFE
76GF Score
JFL Life Sciences Ltd NSE:JFLLIFE
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JFL Life Sciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

JFL Life Sciences's Ending Cash Position for the fiscal year that ended in Mar. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.33999999999999+8.29
=8.6

JFL Life Sciences's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.33999999999999+8.29
=8.6

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ₹8.6 Mil mean?
JFL Life Sciences (NSE:JFLLIFE) has a Ending Cash Position of ₹8.6 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on JFL Life Sciences and its competitors.
Is JFL Life Sciences' Ending Cash Position too high?
JFL Life Sciences' current Ending Cash Position is ₹8.6 Mil. Overall, JFL Life Sciences has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' Ending Cash Position compare to ZTS?
JFL Life Sciences' Ending Cash Position of ₹8.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on JFL Life Sciences and its competitors. JFL Life Sciences's current Ending Cash Position is ₹8.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹36.85, compared to a current price of ₹9.80 — trading 73.4% below its estimated fair value. The current Ending Cash Position is ₹8.6 Mil. JFL Life Sciences' overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current Ending Cash Position is ₹8.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued. The current stock price of ₹9.80 is trading 73.4% below its estimated GF Value™ of ₹36.85. GuruFocus considers JFL Life Sciences to be Significantly Undervalued.

Key valuation signals for NSE:JFLLIFE:

  • Ending Cash Position: ₹8.6 Mil
  • GF Value™: ₹36.85 vs. price of ₹9.80 (73.4% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JFL Life Sciences Business Description

Address Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
76GF Score

Get the complete analysis for NSE:JFLLIFE

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.80
Price
₹36.85
GF Value